Align Technology Inc (ALGN) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90%...
Align Technology Inc (ALGN) currently trades at a P/E ratio of 26.51 (historical range: 20.86–43.33, median: 31.39), placing it at the 16th percentile — cheap relative to its history, P/S ratio of 2.78 (range: 2.29–4.91, 19th percentile — cheap relative to its history).
Over the historical period (2024-08-30 to 2026-08-28), Align Technology Inc's P/E ratio has contracted by 14% over the observed period (from an average of 33.9 to 29.1).
Align Technology Inc appears significantly undervalued relative to its historical range, trading at depressed multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 26.51 | 20.86 | 31.39 | 43.33 | 16th | cheap relative to its history |
| P/S Ratio | 2.78 | 2.29 | 3.17 | 4.91 | 19th | cheap relative to its history |
| FCF Yield | 0.01 | 0.00 | 0.01 | 0.05 | 41th | near its historical average |